Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Foreign establishment registration and listing. Final rule.

    Federal Register
    |January 5, 2002
    PubMed
    Summary
    This summary is machine-generated.

    The U.S. Food and Drug Administration (FDA) finalized a rule requiring foreign establishments to register and name a U.S. agent for products imported into the U.S. This enhances regulatory oversight for human drugs, animal drugs, biologics, and devices.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Findings of Research Misconduct.

    Federal register·2026
    Same journal

    Findings of Research Misconduct.

    Federal register·2026
    Same journal

    Findings of Research Misconduct.

    Federal register·2026
    Same journal

    Findings of Research Misconduct.

    Federal register·2025
    Same journal

    Findings of Research Misconduct.

    Federal register·2025
    Same journal

    Findings of Research Misconduct.

    Federal register·2024
    See all related articles

    Area of Science:

    • Regulatory Science
    • Pharmaceutical Policy
    • Medical Device Regulation

    Background:

    • The U.S. Food and Drug Administration (FDA) regulates products imported into the United States.
    • Existing regulations govern the registration and listing of medical products.
    • The Food and Drug Administration Modernization Act of 1997 (FDAMA) introduced provisions for foreign establishment registration.

    Purpose of the Study:

    • To amend FDA regulations concerning the registration and listing of foreign establishments and their products.
    • To implement Section 417 of FDAMA regarding foreign establishment registration.
    • To enhance the oversight of human drugs, animal drugs, biological products, and devices imported into the U.S.

    Main Methods:

    • Issuance of a final rule by the FDA.
    • Amendment of existing FDA regulations.
    • Mandating registration of foreign establishments that import or offer products for import into the U.S.

    Main Results:

    • Foreign establishments must register with the FDA.
    • Foreign establishments must designate a United States agent.
    • The final rule pertains to human drugs, animal drugs, biological products, and devices.

    Conclusions:

    • The final rule establishes clear requirements for foreign establishments.
    • Implementation of Section 417 of FDAMA is achieved through this amendment.
    • Enhanced regulatory compliance and safety for imported products are anticipated.